CPIM
PFE icon

Columbia Partners Investment Management’s Pfizer PFE Stock Holding History

Columbia Partners Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-64,424
Closed -$2.17M – 213
2018
Q1 		$2.17M Buy
64,424
+18,104
+39% +$622K 0.28% 109
2017
Q4 		$1.59M Sell
46,320
-13,158
-22% -$449K 0.21% 135
2017
Q3 		$2.01M Buy
59,478
+3,908
+7% +$126K 0.27% 118
2017
Q2 		$1.77M Buy
55,570
+2,013
+4% +$63.5K 0.23% 128
2017
Q1 		$1.74M Buy
53,557
+5,603
+12% +$177K 0.22% 128
2016
Q4 		$1.48M Sell
47,954
-4,148
-8% -$127K 0.13% 198
2016
Q3 		$1.67M Buy
52,102
+771
+2% +$25.8K 0.13% 207
2016
Q2 		$1.71M Buy
51,331
+1,305
+3% +$41.6K 0.13% 215
2016
Q1 		$1.41M Buy
50,026
+3,008
+6% +$85.9K 0.1% 222
2015
Q4 		$1.44M Buy
47,018
+17,268
+58% +$543K 0.1% 216
2015
Q3 		$886K Buy
+29,750
New +$954K 0.06% 279
2015
Q2 		– Sell
-31,539
Closed -$1.04M – 357
2015
Q1 		$1.04M Sell
31,539
-11,503
-27% -$366K 0.06% 229
2014
Q4 		$1.27M Sell
43,042
-3,050
-7% -$87.5K 0.07% 224
2014
Q3 		$1.29M Sell
46,092
-83,609
-64% -$2.35M 0.07% 227
2014
Q2 		$3.65M Sell
129,701
-108,172
-45% -$3.08M 0.17% 172
2014
Q1 		$7.25M Sell
237,873
-145,283
-38% -$4.33M 0.32% 115
2013
Q4 		$11.1M Buy
383,156
+36,452
+11% +$1.06M 0.48% 67
2013
Q3 		$9.45M Buy
346,704
+36,399
+12% +$990K 0.42% 84
2013
Q2 		$8.25M Buy
+310,305
New +$8.57M 0.39% 93

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Columbia Partners Investment Management's PFE Position: Q2 2018 in Review

Columbia Partners Investment Management sold out of Pfizer (PFE) in Q2 2018, closing a stake of 64,424 shares — an estimated $2.17M sold.

Columbia Partners Investment Management first reported a position in PFE in Q2 2013 and held it in 19 quarters. The position peaked at $11.1M in Q4 2013. 2,205 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

  • Columbia Partners Investment Management reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
  • Columbia Partners Investment Management sold 64,424 Pfizer shares in Q2 2018, an estimated $2.17M.
  • Columbia Partners Investment Management first reported a position in Pfizer in Q2 2013 and held it in 19 quarters.
  • Columbia Partners Investment Management's Pfizer position peaked at $11.1M in Q4 2013.
  • 2,205 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Columbia Partners Investment Management's 13F filing for Q2 2018, filed 12 Jul 2018.